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X-Linked Cone Dystrophy Caused by Mutation
of the Red and Green Cone Opsins
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Michel Michaelides,1,2,* and Alison J. Hardcastle1,*
X-linked cone and cone-rod dystrophies (XLCOD and XLCORD) are a heterogeneous group of progressive disorders that solely or
primarily affect cone photoreceptors. Mutations in exon ORF15 of the RPGR gene are the most common underlying cause. In a previous
study, we excluded RPGR exon ORF15 in some families with XLCOD. Here, we report genetic mapping of XLCOD to Xq26.1-qter.
A signiﬁcant LOD score was detected with marker DXS8045 (Zmax ¼ 2.41 [q ¼ 0.0]). The disease locus encompasses the cone opsin
gene array on Xq28. Analysis of the array revealed a missense mutation (c. 529T>C [p. W177R]) in exon 3 of both the long-wavelength-
sensitive (LW, red) andmedium-wavelength-sensitive (MW, green) cone opsin genes that segregated with disease. Both exon 3 sequences
were identical andwere derived from theMWgene as a result of gene conversion. The amino acidW177 is highly conserved in visual and
nonvisual opsins across species. We show that W177R in MWopsin and the equivalent W161R mutation in rod opsin result in protein
misfolding and retention in the endoplasmic reticulum. We also demonstrate that W177R misfolding, unlike the P23Hmutation in rod
opsin that causes retinitis pigmentosa, is not rescued by treatment with the pharmacological chaperone 9-cis-retinal. Mutations in the
LW/MW cone opsin gene array can, therefore, lead to a spectrum of disease, ranging from color blindness to progressive cone dystrophy
(XLCOD5).Introduction
X-linked cone dystrophy (XLCOD) and X-linked cone-rod
dystrophy (XLCORD) are a heterogeneous group of disor-
ders in which there is dysfunction and degeneration of
cone photoreceptors, often followed by later rod dysfunc-
tion.1 Affected males present in childhood or early adult
life with a variable degree of photophobia, reduced central
vision, and color-vision disturbance. Later in the disease
there may be nyctalopia and peripheral-ﬁeld loss.1 Muta-
tions in the RPGR gene (MIM 312610) on Xp21 are the
most common known cause of XLCOD/XLCORD (MIM
304020; COD1/ CORDX1), and all of the reported muta-
tions are found in exon ORF15.2–5 XLCORD (COD3/
COD4/CORDX3 [MIM 300476]) has also been described
in one family from Finland with a mutation in the
CACNA1F gene (MIM 300110) on Xp11.23, and an addi-
tional locus has been reported to map within the interval
bounded by markers DXS292 and DXS1113 on Xq27
(MIM 300085; COD2/CORDX2).6,7
Here, we describe mapping of the disease interval in an
XLCOD family to Xq26.1-qter. We subsequently identiﬁed
the causative gene mutation as a missense mutation
(c. 529T>C [p.W177R]) in both the long-wavelength-
sensitive (LW) and the medium-wavelength-sensitive
(MW) cone opsin genes, and we investigated the func-
tional consequence of this mutation.1UCL Institute of Ophthalmology, 11-43 Bath Street, London EC1V 9EL, UK; 2M
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Patients and Clinical Assessment
The protocol of the study adhered to the provisions of the Decla-
ration of Helsinki and was approved by the local ethics committee
at Moorﬁelds Eye Hospital. A three-generation British family,
consisting of six affected male subjects and three obligate females,
was ascertained as having XLCOD (Figure 1). Four affected individ-
uals and two obligate carrier females were available for detailed
assessment. Clinical notes and fundus images were reviewed for
the two remaining affected males. After informed consent was
obtained, blood samples were taken from family members and
genomic DNA was extracted by standard techniques. A full
medical history was taken and an ophthalmological examination
was performed. Affected male subjects and obligate carrier females
underwent color fundus photography, fundus autoﬂuorescence
imaging (HRA2, Heidelberg Engineering, Heidelberg, Germany),
color-vision testing, and electrophysiological assessment, which
included a full-ﬁeld electroretinogram (ERG) and pattern
ERG (PERG), incorporating the standards of the International
Society for Clinical Electrophysiology of Vision (ISCEV).8,9 A
dark-adapted ‘‘bright ﬂash’’ ERG was additionally recorded to
a ﬂash strength of 11.5 cd.s.m2, better to demonstrate the photo-
receptor-mediated a-wave. Long-duration ON-OFF ERGs used an
orange stimulus (560 cd.m2, duration 200 ms) superimposed on
a green background (150 cd.m2). Short-wavelength ﬂash ERGs
used a blue stimulus (5 ms in duration, 445 nm, 80 cd.m2) on
an orange background (620 nm, 560 cd.m2).10 One affected
male was unable to tolerate corneal electrodes, and full-ﬁeldoorﬁelds Eye Hospital, City Road, London EC1V 2PD, UK; 3West Midlands
2TT, UK
k (A.J.H.)
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Figure 1. Pedigree and Haplotype Analysis of the XLCOD Family, Defining the Critical Interval as Xq26.1-qter
(A) Haplotypes for markers on Xp show that the disease does not segregate with known disease genes (RPGR, RP2, and CACNA1F).
(B) XLCOD segregates withmarkers on Xq26.1-qter. The affected haplotype is shaded black. Individuals II:4, II:6, and III:6 have a recom-
bination between markers DXS1047 and DXS984, deﬁning the proximal boundary of disease. No distal recombinations were identiﬁed;
thus, the critical interval is deﬁned as DXS1047-Xqter. The location of the LW/MWopsin array is indicated. Haplotypes are shown ac-
cording to marker order on the X chromosome, as indicated in the key. Filled symbol, affected; empty symbol, unaffected; circles with
dots, obligate carrier females; ?, affectation status unknown.ERGs were recorded with the use of lower-eyelid-skin electrodes
(Table 1).11 Color-vision tests were also carried out with the use
of Ishihara pseudoisochromatic plates, Hardy, Rand, and Rittler
(HRR) plates (American Optical Company, NY), the City Univer-
sity color vision test, the Farnsworth-Munsell (FM) D-15 and
FM-100-hue tests, and Rayleigh and Moreland anomaloscope
matches. The FM 100-hue test and other plate tests were per-
formed under CIE Standard Illuminant C from a MacBeth Easel
lamp or Illuminant D50 (daylight) from a daylight lighting booth.
Observer II:1 was unable to perform these tests because of his very
poor visual function.Psychophysical Experiments
The psychophysical measurements were made with the use of
a Maxwellian-view optical system, as described previously.12–14
In all experiments, a ﬂickering target of 4 of visual angle in diam-
eter was presented in the center of a 9 diameter background ﬁeld.
Fixation was central. Each data point for the individual measure-
ments represents the average of at least three settings. For L-cone
critical ﬂicker fusion (cff) measurements, the wavelength of theThtarget was ﬁxed at 650 nm, and its radiance varied from 6.5 to
11.0 log10 quanta s
1 deg2 in steps of about 0.3 log10 units. The
target was superimposed in the center of a 481 nm background
that delivered 8.29 log10 quanta s
1 deg2 at the cornea. This back-
ground served mainly to suppress rods, but also selectively desen-
sitized M-cones at lower target radiances. For S-cone cff measure-
ments, the wavelength of the target was ﬁxed at 440 nm, and its
radiance was varied from 6.5 to 11.0 log10 quanta s
1 deg2. The
target was superimposed in the center of a 620 nm background
of 11.35 log10 quanta s
1 deg2. The 620 nm background ﬁeld
selectively desensitized the M- and L-cones, but it had compara-
tively little direct effect on the S-cones. For normal observers,
this ﬁeld isolates the S-cone response up to a 440 nm target radi-
ance of about 10.0 log10 quanta s
1 deg2, as also evidenced by
the change in slope of the normal S-cone cff near that radiance,
above which M-cones contribute to ﬂicker detection.15–17 For cff
measurements, the observers adjusted the ﬂicker frequency to
ﬁnd the frequency at which the ﬂicker just disappeared (this
frequency is known as the ‘‘critical ﬂicker fusion’’ frequency).
For spectral-sensitivity measurements, the wavelength of the
target was varied in approximately 30 nm steps. The target wase American Journal of Human Genetics 87, 26–39, July 9, 2010 27
Table 1. Summary of Clinical Findings
Case Sex Age VA: OD, OS
Refraction:
OD, OS Fundus
Psychophysical
Testing PERG ERGs
IV:1 M 27 6/24, 6/36 5.5/1.75 3 45,
4.5/1.5 3 135
mild bilateral macular
RPE disturbance with
peripheral pigmentary
and atrophic changes
minimal evidence for
M- or L-cone function,
good S-cone function
undetectable: severe
macular dysfunction
severe bilateral
generalized cone
dysfunction,
undetectable
S-cone ERG
IV:2 M 26 6/36, 6/36 5.0/1.75 3 100,
4.5/1.75 3 90
bilateral macular
RPE disturbance
no evidence for M-
or L-cone function,
good S-cone function
undetectable: severe
macular dysfunction
(skin electrodes)
severe generalized
cone dysfunction,
undetectable S-cone
ERG (skin electrodes)
IV:4 M 14 6/18, 6/18 5.75/2.5 3 180,
7.0/1.75 3 180
mild bilateral
macular RPE
disturbance
no evidence for M-
or L-cone function,
good S-cone function
undetectable: severe
macular dysfunction
severe generalized
cone dysfunction with
preserved low
amplitude S-cone ERG
III:1 F 56 6/9, 6/9 3.0/0.5 3 180,
3.0/1.0 3 90
bilateral macular
RPE changes
and drusen
reduced L-cone
sensitivity, normal
on color vision tests
reduced: moderate
macular dysfunction
mild generalized cone
dysfunction with
undetectable
S-cone ERG
III:4 F 43 6/6, 6/5 5.0/0.75 3 175,
4.0/2.25 3 35
mild bilateral
macular RPE
changes
reduced L-cone
sensitivity, normal
on color vision tests
reduced multifocal
ERGs: mild macular
dysfunction
mild generalized cone
dysfunction, with
relatively preserved
S-cone ERGs
II:1 M 82 CF, CF 3.0/1.5 3 80,
3.0/2.25 3 90
bilateral, well-
demarcated
macular atrophy
no evidence for M-
or L-cone function,
minimal residual
S-cone function
undetectable: severe
macular dysfunction
severe generalized
cone dysfunction
with relatively
preserved S-cone ERG
II:3 M 80 6/60, CF 4.0/1.0 3 65,
3.5/1.5 3 90
bilateral, well-
demarcated
macular atrophy
NP NP NP
II:4 M 72 6/60, 6/60 7.0/1.0 3 180,
7.0/1.0 3 180
bilateral, well-
demarcated
macular atrophy
NP NP NP
Abbreviations are as follows: CF, count fingers; ERG, electroretinogram; NP, not performed; PERG, pattern ERG; RPE, retinal pigment epithelium; VA, visual acuity.sinusoidally ﬂickered at 5 Hz and was superimposed in the center
of the same 481 nm background used in the L-cone cff measure-
ments. At each target wavelength, the observer adjusted the target
radiance to ﬁnd the radiance at which the ﬂicker just disappeared
(this radiance is known as the ‘‘ﬂicker threshold’’).Haplotype and Linkage Analysis
Genotyping was performed with the use of microsatellite markers
across the X chromosome, according to the manufacturer’s proto-
cols (ABI prism linkage mapping set version 2.5 and additional
microsatellite markers; primers and conditions available upon
request). Two-point linkage analysis for XLCOD and informative
markers was performed for calculation of LOD scores with the
use of MLINK version 5.1 (Columbia University, NY). The XLCOD
disease-allele frequency was set at 0.0001. The penetrance value
for carrier females was set at 0.0000. Alleles at marker loci were
assumed to have equal frequency. Genetic distance and marker
order used for haplotype analysis and two-point linkage analysis
were assigned according to genetic and physical maps obtained
from NCBI and UCSC.PCR and Sequence Analysis of the Cone Opsin Array
The cone opsin gene array is composed of a locus control region
(LCR) that controls transcription of one long-wavelength-sensi-
tive (red) opsin gene (OPN1LW [MIM 303900], herein referred to28 The American Journal of Human Genetics 87, 26–39, July 9, 2010as LW) and one medium-wavelength-sensitive (green) opsin
gene (OPN1MW [MIM 303800], herein referred to as MW). The
LW and MW genes in the genomic array are organized in a head-
to-tail tandem arrangement with a single LW opsin gene in a 50
position, followed by one or more MW opsin genes.18,19 The
number of MW genes in the array is polymorphic. However,
only the ﬁrst MW gene is expressed.20–22 Genomic DNA from an
affected male (subject IV:2) was screened for mutations in the
LCR and exons 1 to 6 of the LW/MW opsin gene array by PCR
ampliﬁcation and direct sequencing, as described previously.23
In the initial screen, common primer pairs designed to coamplify
both LW and MW genes were used. Sequences were compared
with reference sequences. Sequence electropherograms of these
amplicons revealed a dual peak at sites of known nucleotide vari-
ation between the LW and MW genes. The coding sequence of
exons 1 and 6 of LW and MW are identical; however, sequence
upstream of the start codon of exon 1 harbors nucleotide differ-
ences that facilitated identiﬁcation of both MW and LW exon 1.
After the preliminary screen of the cone opsin array, exons 2, 3,
and 4 of both genes were further studied with the use of LW-
and MW-gene-speciﬁc primers (primer sequences and conditions
available on request). These speciﬁc primers were used to conﬁrm
the presence or absence of an exon in the array. The speciﬁc
primers were then paired with the coampliﬁcation primers in
a series of long-range PCR ampliﬁcations to determine the struc-
ture of the array and the relationship of each LW or MW exon to
its 50 and 30 neighbor (primer sequences and conditions available
on request). High-ﬁdelity PCRmaster mix (Abgene, Thermo Fisher
Scientiﬁc) was used for PCR reactions according to the manufac-
turer’s protocols. PCR products were then puriﬁed enzymatically
with ExoSAP-IT (GE Healthcare) and bidirectionally sequenced
(Applied Biosystems) according to the manufacturer’s protocols.
The sequence was examined with Lasergene DNA Star software
(DNA Star). Identiﬁed sequence changes were tested for segrega-
tion with disease in the family. PCR products of exon 3 (coampli-
ﬁcation of both LW and MW) for over 200 control chromosomes
were analyzed for the mutation with the use of an MspI (New
England Biolabs) restriction digest assay that was diagnostic for
the presence of the mutation.Constructs, Antibodies, and Reagents
To create cone opsin constructs with a 1D4 epitope for transient
transfection, we subcloned 1D4-tagged green (MW) opsin with
a C203R mutation from pGrnC203R24 into pBK-CMV. Using
site-directed mutagenesis (Quickchange, Stratagene), we produced
a wild-type (WT) green opsin construct and subsequently created
a construct with the W177R mutation (primers available on
request). Untagged and green ﬂuorescent protein (GFP)-tagged
WT rod opsin and untagged and GFP-tagged P23H mutant rod
opsin were generated as previously described.25 Site-directed
mutagenesis was used to introduce the W161R mutation in
untagged andGFP-tagged rod opsin (primers available on request).
The primary antibodies used were 1D4 and anti-calnexin (C4731,
Sigma). The secondary antibodies used were HRP-conjugated goat
anti-mouse (Pierce) and Alexa Fluor 488 anti-mouse or Alexa Fluor
594 anti-rabbit (Invitrogen). 9-cis-retinal was from Sigma and
Endo H from New England Biolabs.Immunoblotting and Immunocytochemistry
SK-N-SH cells weremaintained and transfected essentially as previ-
ously described.26,27 In brief, in the rescue experiments, 10 mM
9-cis-retinal was added after transfection and the cells were main-
tained in the dark. For immunoblotting, cells were lysed 24 hr after
transfection with 0.1% n-dodecyl-b-D-maltoside (DM) buffer with
a protease-inhibitor cocktail (Sigma) in PBS, and cleared lysates
were resolved on 10% SDS-PAGE gels. Immunodetection of both
cone opsin and rod opsin was carried out with the use of the 1D4
antibody. For deglycosylation experiments, lysates were treated
with Endo H for 2 hr at 37C prior to SDS-PAGE. For immunocyto-
chemistry, cells were seeded on 8-well permanox chamber slides
and transfected with GFP-tagged rod opsin constructs or 1D4
epitope-tagged cone opsin constructs. Twenty-four hours after
transfection, cells were ﬁxed with 4% paraformaldehyde and
permeabilized in 0.1% Triton X-100. Cells transfected with cone
opsins were incubated with 1D4 (0.5 mg/ml) and anti-calnexin
(1:600), followed by secondary antibodies Alexa Fluor 488 anti-
mouse and Alexa Fluor 594 anti-rabbit (1:2000). Images were taken
with a Zeiss LSM 700 laser scanning confocal microscope. The
images were exported from Zen 2009 Light Edition, and ﬁgures
were prepared with Adobe Photoshop and Illustrator CS2.Results
Assessment of Phenotype
Affected subjects were aged between 14 and 82 yrs and
complained of reduced central vision starting in the ﬁrstThdecade, with subsequent gradual deterioration of visual
acuity (VA) and color vision. Clinical ﬁndings are summa-
rized in Table 1. VA ranged from 6/18 to counting ﬁngers.
All affected males were myopic. One subject had nys-
tagmus (26 yrs old), and the remaining subjects did not
report a history of nystagmus. A range of macular appear-
ances was seen, varying from mild retinal pigment epithe-
lial (RPE) changes in the younger subjects to extensive
macular atrophy in the older generation (Figure 2A). Auto-
ﬂuorescence imaging was within normal limits in the three
youngest affected subjects. From the older generation,
subject II:1 was available for imaging and had evidence
of bilateral perimacular rings of increased autoﬂuores-
cence. Both obligate carriers were asymptomatic and had
mild bilateral macular RPE changes; although in one
(III:1) these were associated with drusen andmay therefore
be age-related. Autoﬂuorescence imaging was unremark-
able in both carriers. An asymptomatic subject, IV:6, was
also reviewed and had a normal ocular examination.
All four affected subjects (IV:1, IV:2, IV:4, and II:1) had
severely abnormal photopic full-ﬁeld ERGs consistent
with severe generalized cone system dysfunction (Fig-
ure 2B). Dark-adapted ERGs to a dim ﬂash were normal
(seven eyes) or borderline subnormal (one eye; IV:2), in
keeping with preserved or relatively preserved rod system
function. The scotopic bright ﬂash ERG (ISCEV ‘‘sug-
gested’’; mixed rod-cone response) for II:1 and IV:4 showed
mild a-wave reduction. All four had undetectable PERGs
consistent with severe macular dysfunction. ON-OFF
ERGs were severely subnormal in all cases. Short-wave-
length ﬂash ERGs, normally characterized by early (L-cone
andM-cone system) and late (S-cone system) components,
were subnormal in two subjects (IV:1 and IV:2) and were
preserved in subjects II:1 and IV:4 (Figure 2B). Both obli-
gate carriers (III:1 and III:4) had electrophysiological evi-
dence of mild generalized cone system dysfunction with
moderate macular involvement (PERG in III:1 and multi-
focal ERG in III:4) (Figure 2B).
Color vision testing performed in the three youngest
affected patients (IV:1, IV:2, and IV:4) revealed evidence
of good tritan discrimination with no measurable discrim-
ination along protan or deutan axes. No discernable color
discrimination was possible in the eldest affected male
(II:1) because of poor VA; however, psychophysical exper-
iments detailed below established that he had only
minimal residual S-cone function at the macula. The obli-
gate carrier females performed normally on all standard
color vision tests.
Psychophysical Data
L-cone cff measurements28,29 for two affected males (IV:1
and IV:4) showed a devastating loss of L- andM-cone sensi-
tivity (Figure 2C). The target had to be set 104 times brighter
than the setting for normal observers in order for the
affectedmales toﬁrst seeﬂicker.Control experiments carried
out on subject IV:1 suggested that detection at these high
levels may be partially mediated by rods. Consistent withe American Journal of Human Genetics 87, 26–39, July 9, 2010 29
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Figure 2. Phenotype of the XLCOD5
Family
(A) Color fundus photographs of affected
male patient II:3 (80 yrs old), showing
symmetrical bilateral macular atrophy.
(B) PERG and full-ﬁeld ERGs for affected
males IV:4, IV:1, and II:1 and obligate
carrier females III:1 and III:4, as indicated,
compared with those from a representa-
tive normal subject (bottom row). Record-
ings were performed with gold-foil
corneal electrodes. Broken lines replace
eye-movement artifacts.
(C)L-conecffmeasurements (i,upperpanel)
for two affected males (IV:1 and IV:4) and
two obligate carriers (III:1 and III:4), show-
ing signiﬁcant loss of L- and M-cone sensi-
tivity in affected males and reduced L-cone
sensitivity in both carriers as compared
to controls. S-cone critical ﬂicker fusion
measurements (i, lower panel) for three
affectedmales (IV:1, IV:4, and II:1), showing
signiﬁcant S-cone sensitivity loss in the
eldest affected male (II:1) as compared to
controls. Spectral-sensitivity measurements
(ii) for the three youngest affected
males (IV:1, IV:2, and IV:4), showing
substantial losses of ﬂicker sensitivity at
middle and long wavelengths, but sensitiv-
ities at short wavelengths that are nearly
normal.
Error bars represent51 SEM.
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Table 2. Two-Point Linkage Analysis between XLCOD and
Microsatellites on the X Chromosome
LOD Score at Recombination Fraction (q) of:
Locus
Position
ChrX 0.00 0.05 0.10 0.20 0.30 0.40
Xp
DXS1214 31160748 N 2.88 1.77 0.77 0.30 0.07
DXS8102 38118315 0.05 0.03 0.02 0.01 0.00 0.00
DXS1068 38807989 N 2.88 1.77 0.77 0.3 0.07
DXS8015 38987415 N 1.53 0.94 0.40 0.15 0.04
DXS0993 41047637 N 1.47 0.91 0.39 0.15 0.03
DXS8080 44143324 N 1.5 0.92 0.40 0.15 0.04
DXS8083 45141390 N 2.88 1.77 0.77 0.3 0.07
DXS1055 46326364 N 2.88 1.77 0.77 0.3 0.07
DXS991 55419039 N 2.88 1.77 0.77 0.3 0.07
Xq
DXS1205 140162266 1.37 1.31 1.22 1.00 0.73 0.40
DXS1227 140702381 0.90 0.81 0.72 0.52 0.30 0.09
DXS8106 142084035 1.41 1.33 1.24 1.01 0.73 0.40
DXS8045 145412040 2.41 2.21 2.00 1.54 1.03 0.49
DXS1073 153728848 1.45 1.36 1.26 1.04 0.73 0.40a partial loss of L-cone function, both of the carrier females
(III:1 and III:4) show some loss in cff as compared tonormal.
The loss in III:1 was more than that of her younger sister,
III:4, averaging at about 10 Hz across levels. S-cone cff15–17
showed that the two younger affected males (IV:1 and IV:4)
havenormal S-cone function. By contrast, the older affected
male (II:1) showed a considerable S-cone sensitivity loss,
with ﬂicker seen only at the highest radiances (Figure 2C).
Spectral-sensitivity measurements were made in the
three youngest affected males. The data for IV:2 and IV:4
have been shifted down for clarity by 3.5 and 7 log10 units,
respectively (Figure 2C). The S- and M-cone and rod [or
V’(l)] spectral-sensitivity curves ﬁtted to the data for the
affected males are standard functions.30,31 Compared to
the normal, all three subjects showed a substantial loss of
ﬂicker sensitivity atmiddle and longwavelengths, but their
sensitivities at short wavelengths were nearly normal
(Figure 2C). Detection at short wavelengths was consistent
with detection by the S-cones. Detection at longer wave-
lengths is mediated by rods in IV:2 and IV:4. The data for
IV:1, however, suggest that his rods are more insensitive.
These psychophysical data cannot entirely exclude the
possibility that some residual L- or M-cone function
remains in the affected younger males, particularly in the
case of observer IV:1. If there is any residual function,
however, it must be attenuated by more than 4 log10 units
compared to normal.Deﬁning the Disease Interval for XLCOD
Screening of RPGR in an affected male from this family did
not reveal amutation.4We then performed X chromosome
haplotype analysis in order to deﬁne the genetic interval
segregating with cone dystrophy in the family. Haplotype
analysis demonstrated that markers on Xp did not segre-Thgate with disease (Figure 1A) and excluded RPGR, RP2 (MIM
300757), and CACNA1F as candidate genes. A common
haplotype that segregated with disease was identiﬁed in
affected males and obligate carrier females on Xq (Fig-
ure 1B). The proximal boundary of the genetic interval was
deﬁned by a recombination between markers DXS1047
and DXS984, which mapped the disease locus in this
family to Xq26.1-qter, spanning approximately 26 Mb and
containing 388 genes. Two-point LOD scores were calcu-
lated for markers on Xq (Table 2), and a signiﬁcant LOD
score was generated for marker DXS8045, Zmax ¼ 2.41
(q ¼ 0), on Xq27.3. The cone opsin gene array on Xq28
was thereby a positional candidate for disease.
Identiﬁcation of a Missense Mutation in Exon 3
of the MW Cone Opsin Gene
In the preliminary screen of the opsin array, the LCR and
exons 1–6 of the LW/MWopsins of an affected individual
(IV:2) were ampliﬁed and sequenced. Sequence analysis
demonstrated the presence of an intact LCR and the pres-
ence of exons 1, 2, 4, 5, and 6 of the LW and MW genes
(Figure S1, available online). At nucleotide c.706 in exon
4, a single peak was observed (Figure S1), representing an
A>G transition in the LW gene resulting in the known
SNP p.M236V. Interestingly, sequence analysis of exon 3
revealed a single MW-derived sequence (Figure S1 and Fig-
ure 3B). The exon was identiﬁed as MW, because single
peaks representing MW gene common alleles were present
at four positions (c.A453, c.A457 [p.M153], c.C465, c.G538
[p.A180]) out of a possible six nucleotide differences
between MW and LW genes in exon 3. The allele c.G538
encodes the MW gene spectral-tuning amino acid p.A180
(Figure 3B).32 Two additional known nonsynonymous
SNPs, c.521C>T (p.A174V) and c.532A>G (p.I178V), were
also identiﬁed in MW exon 3 (Figure 3B). Importantly,
a missense mutation, c.529T>C, was also detected in MW
exon 3, creating a Trp-to-Arg change in a highly conserved
residue at p.177 (p.W177R) (Figure 3B). This mutation, and
the SNPs, segregated with disease in the family.
Both the LW and MW Genes Harbor the Mutation
We developed a strategy to determine the organization of
the cone opsin genes in this family. To test whether the
LW copy of exon 3 was deleted, we designed LW-speciﬁc
exon 3 primers. No PCR product was obtained for affected
males. However, control subjects ampliﬁed successfully
(data not shown), indicating that LW exon 3 was likely
to be deleted. Because several array arrangements were
possible (including LW/MW hybrid genes), long-range
PCR was used (Figure 3A) to establish the genomic arrange-
ment of the genes in the array. Speciﬁc ampliﬁcation of
MW exon 3 to MW exon 4 produced the expected 2 Kb
fragment in controls and in affected and unaffected
members of the XLCOD family. Importantly, speciﬁc
ampliﬁcation of MW exon 3 to LW exon 4 resulted in
ampliﬁcation of a 2 Kb fragment in affected members of
the family, but not in controls (data not shown). Thise American Journal of Human Genetics 87, 26–39, July 9, 2010 31
Figure 3. Molecular Analysis of the Cone
Opsin Array and Identification of a
c.529T>C Mutation in Exon 3 of the LW
and MW Cone Opsin Genes
(A) The cone opsin array comprises an
upstream LCR, an LW opsin gene, and
one or more MW opsin genes lying in a
50 to 30 position in tandem on Xq28. Grey
boxes represent LWopsin exons, andwhite
boxes represent MW opsin exons. Exons
are numbered below the ﬁgure. A subscript
‘‘n’’ represents one or more MW opsin
genes. The black box represents the
upstream LCR. After an initial screen of
the LCR and coampliﬁcation of exons of
the LW/MW genes, a strategy was devel-
oped to determine the precise opsin array
structure in the XLCOD5 family. A combi-
nation of gene-speciﬁc primers (labeled
‘‘L’’ or ‘‘M’’) and coampliﬁcation primers
(labeled ‘‘C’’) was used, depicted beneath
the diagrammatical representation of the
opsin array.
(B) Electropherogram of exon 3 in an
affected male (IV:2). Reference sequences
of both LW and MW genes are shown
beneath the patient electropherogram
(XLCOD). The dotted boxes represent
known polymorphic nucleotide variants,
with the resulting amino acid variant
shown above. The lined box highlights
the location of a c.529T>Cmissensemuta-
tion in exon 3 resulting in p.W177R. The
arrow over a dotted box highlights a single
G peak representing sequence derived
from exon 3 of an MW gene only (p.
A180). This indicates that the sequence
changes shown are derived from an MW
exon 3 only. Electropherograms for other
exons (1, 2, 4, 5, and 6) in the affected
male (IV:2) are shown in Figure S1.
(C) Diagrammatic representation of the
cone opsin array in the XLCOD family. Both LW and MW opsin genes contain identical copies of mutant MW exon 3 with the
c.529T>C missense mutation (p.W177R). Polymorphic and nonsynonymous substitutions are also indicated (italic).
(D) Detailed expansion of sequence between exons 2 and 4 of the LW and MWopsin genes in an affected male (XLCOD) compared to
reference sequences. Identiﬁed nucleotide substitutions facilitated further characterization of the gene-conversion event leading to
a mutated MW exon 3 in both the LW and MW genes in the opsin array. Dotted line indicates MW-gene-derived sequence, solid line
indicates LW-gene-derived sequence. The upper and lower dotted lines in the LW opsin gene represent the minimal and maximal
gene-conversion tracts, respectively. IVS2-171G>T and IVS3þ25G>A present in the LW gene are derived from the MW gene, and
they deﬁne the minimal gene-conversion interval surrounding the mutated MW exon 3.suggested that the affected individuals all had a gene in
which MWexon 3 was attached to LWexon 4, in addition
to a WT MW gene. Sequencing of both amplicons in
affected family members conﬁrmed the presence of an
MW exon 3 to LW exon 4 hybrid gene and revealed that
both the hybrid 3MW/4LWgene and theMWgene had the
p.W177R mutation together with p.A174V and p.I178V
SNPs (Figure 3C). The order of exons 1, 2, 3, and 4 in the
array was established by direct sequencing of amplicons
generated by pairing of LWand MW common and speciﬁc
primers (Figure 3B). The length of intron 1 in the LW gene
is ~1282 bp larger than the MW gene. Thus, PCR generated
two fragments of different sizes that were sequenced. This
conﬁrmed that LW exons 1 and 2 were attached to LW
exon 4 but contained the mutant MW exon 3, and it also32 The American Journal of Human Genetics 87, 26–39, July 9, 2010conﬁrmed the presence of an MW gene containing the
mutant MWexon 3 (Figure 3C). The cone opsin gene array
in affected members of the XLCOD family therefore
consists of an LW gene containing a W177R mutant MW
exon 3, followed by an MW gene containing an identical
W177R mutant MW exon 3 (Figure 3C). Analysis of the
intervening sequence ﬂanking the mutant MW exon 3 of
both genes showed that the two genes shared a minimum
identical region (or minimal converted tract) of MW-
derived sequence of 492 bp, from IVS2-170 to IVS3þ25
(Figure 3D). This indicates that W177R was transferred in
a block of exon 3 sequence from the MW gene into the LW
gene by gene conversion. This mutation was not detected
in a population sample of over 200 chromosomes, equiva-
lent to over 400 LW or MW genes.
Figure 4. Secondary Structure of the Cone Opsins and Conservation of W177
(A) The secondary structure of the red (LW) and green (MW) cone opsins. Amino acid differences between the LW and MWopsins are
shown as half-closed circles. W177 in transmembrane domain 4 and C203 are shown as a closed circle.
(B) Sequence alignment encompassing W177 of LW and MWopsins with known visual and nonvisual opsins in a variety of species, as
named on the left. This tryptophan is 100% conserved in all opsins.Cellular and Biochemical Consequence of the W177R
Opsin Mutation
W177 is located in transmembrane helix IVof red and green
opsins (Figure 4A). This residue is highly conserved in all
visual and nonvisual opsins (Figure 4B).33 Because of the
small number of pathogenic mutations identiﬁed, there
have been relatively few studies investigating the effect of
amino acid substitutions on the function of cone opsins.
Over 100 pathogenic mutations have been described in
the rhodopsin gene (MIM180380) as a cause of the degener-
ative retinal disease retinitis pigmentosa (RP); however, the
equivalent residue in rhodopsin (W161) has not been
associated with disease to date. We therefore investigated
the effect of the tryptophan-to-arginine mutation in both
cone opsin and rodopsin in transiently transfected SK-N-SH
cells. A 1D4 epitope-taggedMWopsin constructwas used to
study the fate of the W177R mutation. We compared the
MW W177R mutation to the previously characterized
C203Rmutation,knowntocauseblueconemonochromacy
(BCM [MIM 303700]) and shown to result in protein mis-
folding and endoplasmic reticulum (ER) retention.24 We
also studied the W161R rod opsin mutation in comparison
to the common RP-causing P23Hmisfoldingmutation.25,34
Immunoblot analysis of the WT MW opsin revealed
a major band of approximately 40–50 kDa, with a 35 kDa
species representing other glycosylated forms of the opsin
and higher molecular weight aggregates near the top of the
resolving gel (Figure 5A). The C203R and W177R MW
proteins were expressed at lower levels in comparison to
WT. Treatment with MG132 increased the levels of both
mutant proteins, suggesting that the mutant proteins are
degraded by the proteasome (Figure S2). The C203R and
W177R MW proteins also had a different band pattern
than that of WT protein (Figure 5A), with both resolvingThto a major species of approximately 35 kDa. WTMWopsin
was resistant to the glycosidase EndoH, whereas the C203R
andW177R 35 kDa species were sensitive to Endo H diges-
tion. EndoH removes mannose-rich oligosaccharides that
are added to glycoproteins in the ER, but not the complex
oligosaccharides that are added in the Golgi, suggesting
that the mutant proteins are retained within the ER.
Immunocytochemistry of the C203R and W177R mutants
conﬁrmed that these proteins were retained within the ER,
shown by colocalization with calnexin. Both mutant MW
proteins were also prone to aggregation and formed intra-
cellular inclusions (Figure S3). In contrast, WT MW opsin
trafﬁcked to the plasma membrane, with only some reten-
tion in the ER (Figure 5A).
WT rod opsin protein migrated as multiple bands by
immunoblot analysis, with the major species detected as
a smear between 40 and 55 kDa, representing multiple
glycosylated forms of the protein (Figure 5B). The P23H
and W161R rod opsin mutants were expressed at lower
levels than the WT protein and were sensitive to EndoH.
GFP-tagged WT rod opsin localized to the plasma mem-
brane, with some staining in the ER, whereas both P23H
and W161R localized exclusively to the ER, conﬁrming
that W161R causes rod opsin misfolding (Figure 5B).
W161R was also more prone to aggregation in comparison
to P23H, as judged by increased intracellular inclusion
formation (Figure S3).
It has previously been shown that the addition of
11-cis-retinal or 9-cis-retinal to cells expressing P23H rod
opsin can improve folding and trafﬁc.25,35 Therefore, we
investigated the effect of 9-cis-retinal on cells expressing
the tryptophan-to-arginine substitution in MW opsin
and rod opsin. 9-cis-retinal treatment had no effect on
W177R or C203R, because no change in banding patterne American Journal of Human Genetics 87, 26–39, July 9, 2010 33
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Figure 5. The W177R MW Mutation
Causes a Cone Opsin Misfolding Defect
Resulting in ER Retention
(A) Immunoblot analysis of SK-N-SH cell
lysates (10 ug DM-soluble lysate) trans-
fected with either WT MW opsin (MW),
C203R MW mutant or W177R MW
mutant, with Endo H treatment as indi-
cated, probed with 1D4 opsin antibody.
Both W177R and C203R show fewer glyco-
sylated species as compared to WT and
a shift in glycosylated species following
Endo H treatment (arrowhead). Expression
of WT MWopsin (top), C203R (middle), or
W177R (bottom) in SK-N-SH cells detected
with 1D4 (green in merged panel) and
counterstained for the ER marker calnexin
(Cnx, red in merged panel). WT cone opsin
(MW) is processed in the ER and targeted to
the plasmamembrane (arrowhead), reﬂect-
ing normal biogenesis and trafﬁc of MW
opsin, but both mutants were retained in
the ER and colocalized with calnexin.
(B) Immunoblot analysis of SK-N-SH cell
lysates transfected with WT rod opsin
(RHO) and the P23H and W161R RHO
mutants, with Endo H treatment as indi-
cated, probed with 1D4 antibody. Endo H
treatment results in a shift in glycosylated species of the W161R mutant (arrowhead). Expression of GFP-tagged RHO (top), P23H
(middle), and W161R (bottom) (green) counterstained for calnexin (red). RHO-GFP is detected at the plasma membrane, but both
mutant proteins are retained in the ER.was detected by immunoblot analysis, indicating that the
chromophore did not alleviate the mutant protein-folding
defect. This was conﬁrmed by immunocytochemistry, as
both mutants remained in the ER (Figure 6A). However,
9-cis-retinal treatment of cells expressing P23H rhodopsin
increased the amount of P23H, as detected by immuno-
blotting, and restored trafﬁc of P23H to the plasma
membrane (Figure 6B). Treatment with 9-cis-retinal had
no effect on W161R rhodopsin expression or localization.Discussion
The XLCOD5 Locus
The recent exclusion of RPGR exon ORF15 mutations as
the cause of XLCOD in a number of British families led
us to search for other disease-associated genes.4 In the
family reported here, we mapped the disease locus to
Xq26.1-qter. The proximal part of this disease region over-
laps the distal part of the XLCOD2 region on Xq27;
however, in the XLCOD2 family, recombination excluded
the opsin array on Xq28.7 The locus for XLCOD described
here caused by mutations in the cone opsin genes has
therefore been assigned XLCOD5.Gene Conversion as a Mechanism for the Cone Opsin
Array Disease Haplotype
We have identiﬁed a missense mutation of a highly
conserved residue, p.W177, in the LWandMW cone opsin
genes that segregated with disease. The spontaneous occur-
rence of this inactivating point mutation in both genes is34 The American Journal of Human Genetics 87, 26–39, July 9, 2010unlikely. It is more likely that the W177R mutation origi-
nally occurred in an ancestral MW gene and was then
transferred to the LW gene by a gene-conversion event.
This is supported by the fact that the W177R mutation
in the LW gene was embedded in a block of MW sequence.
The presence of a dinucleotide TT at position IVS-170-171
in both the converted tract and the donor sequence
suggests a possible mechanism for gene conversion. We
postulate that the ancestral LW opsin sequence in our
family had originally contained a TT SNP variant at this
locus, and in combination with the TT variant present in
the MW gene, this could have provided an initiation site
for a gene-conversion event to take place after a double-
stranded break in the LW opsin gene.
The high sequence similarity (96% amino acid identity)
and close linkage of the LWandMW genes predisposes the
array to interlocus gene-conversion events in a manner
similar to those occurring in other gene families with
high homology; for example, the human fetal g-globin
gene cluster, the DRB1 loci of the major histocompatibility
complex class II, and the Rh blood group antigen genes
RHD and RHCE.36–39 Population genetic and statistical
analyses of polymorphism at the opsin array have shown
how gene conversion has contributed to sequence diver-
sity within the array40 and, more recently, how polymor-
phism in the LW gene is maintained through a combina-
tion of both gene conversion and natural selection.41
Gene conversion in the opsin array has also been impli-
cated in the pathogenesis of two cases of BCM caused
by a C203R missense mutation in both LW and MW
genes.42,43 Interestingly, studies of haplotype diversity
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Figure 6. The W177R MW Mutation Is
Not Rescued with 9-cis-Retinal
(A) Immunoblot analysis of SK-N-SH cell
lysates transfected with WT MW opsin,
W177R MW mutant and C203R MW
mutant opsins, with and without 9-cis-
retinal treatment, as indicated. 9-cis-retinal
treatment had no effect on the level or
SDS-PAGE mobility of either of the MW
mutants. Immunoﬂuorescence conﬁrmed
no retinoid-associated changes in the
intracellular trafﬁc of the mutants.
(B) Immunoblot analysis of SK-N-SH cell
lysates transfected with RHO and the
RHO mutants P23H and W161R, with
and without 9-cis-retinal treatment re-
sulted in increased expression of P23H,
but not W161R. 9-cis-retinal treatment
led to an increase in P23H trafﬁc to the
plasma membrane (arrowhead), whereas
W161R was retained in the ER, where it
colocalized with calnexin.have shown that sequence exchange at the opsin array
locus is particularly frequent in exon 3, possibly mediated
by the presence of a recombination hotspot (Chi (c)
sequence element) in the 50 part of the exon.40,41 This
high frequency of gene conversion and recombination is
believed to be partly responsible for the high number of
shared exon 3 polymorphisms (Figure S1) in the LW and
MW genes.43 Some polymorphisms shift the lmax of the
LW opsin into the ‘‘red-orange’’ portion of the visible
spectrum, potentially enhancing color discrimination in
heterozygotes.44,45 It has thus been suggested that puri-
fying selection may be an additional factor for mainte-
nance of exonic polymorphism between the LW and MW
genes, whereas historically their introns have become
homogenized.41
In this XLCOD family, the exon 3 haplotype block in the
LW gene carried by affected individuals contains the muta-
tion (W177R) in linkage disequilibrium with several SNPs
(M153, V171, V174, V178, A180) (Figure S1B). The
frequency of MW gene variants that contain a V174,
V178, and A180 haplotype (Val:Val:Ala), as occurs in our
family, is reportedly greater in individuals with only one
MW opsin gene in the array (0.54 versus 0.16).43 This
suggests that there may be nonrandom distribution
(linkage equilibrium) of the haplotypes in the MW gene
with respect to position in the array, with the proximal
position (immediately downstream of the LW gene) being
preferentially occupied by the Val:Val:Ala MW combina-
tion. Our ﬁndings support the suggested high frequency
of gene conversion events involving exon 3 and the
hypothesis of nonrandom distribution of haplotypes.44
Phenotypes Associated with LW/MW Cone
Opsin Mutations
To date, the ocular phenotypes seen in association with
LWand/or MW cone opsin mutations have been restricted
to the various forms of red-green color deﬁciencyThand stationary cone dysfunction syndromes, including
BCM.46–48 In trichromats, normal color vision requires
a neural comparison between the light-absorption spectra
of the three (SW, LW, and MW) different cone visual
pigments. Among males, variations in red-green color
vision are common and estimated to be approximately
8% for individuals of European descent.20,46 Polymor-
phisms and structural rearrangements within the LW/
MW cone opsin genes are common, and these can alter
the spectral characteristics of the encoded proteins, giving
rise to a range of both normal and defective color-vision
phenotypes within a population.48 Normal variants are
believed to have been generated between the highly
homologous LW and MW genes through ancestral gene
conversions (as has been proposed for the S180A polymor-
phism in exon 3 that results in two spectrally different LW
pigments) or by unequal recombination (as occurs in the
visual pigment hybrids). Individuals with BCM have no
functional LW and MW cones, vision is derived from the
remaining SW cones and rod photoreceptors, and color
discrimination is severely impaired from birth, with poor
central vision, marked photophobia, and pendular
nystagmus.47,48 The molecular genetics underlying BCM
was originally reported by Nathans and colleagues.47 Three
mechanisms leading to BCM are now recognized. The ﬁrst
pathway (60% of all cases) involves a heterogeneous group
of two-step mechanisms in which nonhomologous recom-
bination reduces the number of genes in the LW/MWarray
to one and, in the second step, a mutation inactivates the
residual gene. Inactivating point mutations identiﬁed to
date are C203R, P307L, and R247X.42,43,47 The second
pathway consists of a one-step inactivation of both LW
and MW genes by deletion of the LCR sequence (40% of
all cases).43,47,49–52 A third, more rare, mechanism is dele-
tion of an exon.23,53
Interestingly, the mechanism leading to the XLCOD
phenotype described here is a divergent two-step pathway;e American Journal of Human Genetics 87, 26–39, July 9, 2010 35
inactivation mutation followed by gene conversion,
leading to two nonfunctional genes in the array, which
represents a fourth class of opsin array inactivation.
Lack of Cone Function versus Cone Photoreceptor
Degeneration
Although in the majority of subjects BCM is a stationary
condition, progression has been reported in a small
number of families.23,47,49,54,55 This suggests that instead
of rendering the cones nonfunctional, particular cone
opsin mutation types or other modifying factors could
result in cone photoreceptor loss. Molecular genetic anal-
ysis of the LW/MW opsin array in these cases has shown
deletion of the LCR in two families,47,50 as well as a single
50-LW/MW-30 hybrid gene inactivated by a C203R muta-
tion and a 50-LW/MW-30 gene with deletion of exon 2,
each in a single family.23,54 No molecular diagnosis has
been reported in the remaining family.55 Therefore, there
is currently no clear genotype-phenotype correlation.
We report a misfolding mutation, W177R, in both the
LW and MW opsin genes as a cause of progressive cone
dystrophy. Interestingly, mutation of the MW and LW
cone opsins in this family results in an early-onset cone
dystrophy, with both clinical and psychophysical evidence
of cone cell death (Figure 2). There is psychophysical
evidence consistent with loss of SW cone photoreceptors
over time, with the eldest affected male having minimal
residual SW cone function compared to the younger
affected males. VA was signiﬁcantly worse in the older
generation of males as compared to that of the younger
subjects (Table 1). Further evidence of progression was
seen when comparing the mild macular RPE changes in
the younger subjects with the marked macular atrophy
in all three older males (Figure 2, Table 1). The clinical
and psychophysical evidence of progression and gradual
loss of SW cones seen in this family would not be typical
of BCM. Unlike BCM, all subjects also described a deﬁnite
history of better VA and color discrimination in early life
that deteriorated over time. Furthermore, the VA in the
youngest individual (IV:4) is better thanwould be expected
in the vast majority of cases of BCM.23,48,54 In addition, in
BCM the fundus appearance is normal in infancy and early
life and may well remain normal throughout life, whereas
the younger affected subjects in the XLCOD5 family all
had macular RPE disturbance. Nystagmus, photophobia,
and poor vision is evident from either birth or very early
infancy in BCM, whereas onset in the XLCOD5 family
was either several years after birth or toward the end of
the ﬁrst decade, with only one subject (IV:2) having
nystagmus from an early age, and no individuals com-
plaining of photophobia. Taken together, the phenotype
observed in this family is more consistent with progressive
COD than with BCM.
On the basis of the crystal structure of rhodopsin and
comparative modeling with cone opsins,56,57 mutation of
this conserved tryptophan residue would be predicted to
cause a major conformational change in the structure of36 The American Journal of Human Genetics 87, 26–39, July 9, 2010the encoded protein, such that mutant W177R LW and
MW cone opsins would be nonfunctional in their respec-
tive photoreceptors. Misfolding class II mutations in rod
opsin cause ER stress, aggregate, and exert a dominant-
negative effect on the WT protein.58,59 Therefore, in addi-
tion to the loss of functional photopigment, a similar
buildup of misfolded protein in both LW and MW photo-
receptors could result in the cone dystrophy phenotype.
We explored the biochemical and cellular consequence of
this mutation in both cone opsin (MW) and rod opsin,
and we compared this mutant with the most common
point mutation associated with BCM, C203R, and the
RP-associated rod opsin class II misfolding mutant P23H.
The W177R MW mutant and the equivalent mutation in
rod opsin (W161R) were retained in the ER, formed inclu-
sions, and were targeted for degradation by the protea-
some. Similarly, the C203R MW mutant, which results in
misfolded protein due to disruption of a disulphide bond
with C126, was retained in the ER, as reported previ-
ously.24We then tested the ability of 9-cis-retinal treatment
to rescue the protein-processing defect of all four mutants.
Although P23H trafﬁc was partially rescued after treat-
ment, the mutants MW C203R, W177R, and rod opsin
W161R were not affected by 9-cis-retinal. Although the
W177R mutation results in protein misfolding and reten-
tion in the ER in a manner similar to that of the C203R
mutation, the physiological difference between the result-
ing severity in phenotype of the C203R in stationary
disease and W177R in XLCOD5 is currently not clear,
and it may involve other genetic or environmental modi-
fying factors. We have demonstrated that the W177R
mutation results in misfolding of cone opsin, such that
cone degeneration may result from the loss of functional
photopigment, ER stress, and the accumulation of struc-
turally defective opsin, similar to mutations in rod opsin
that cause autosomal-dominant RP.58,59 The equivalent
amino acid in rhodopsin (W161) is thought to be involved
in packing interactions between transmembrane helices III
and IV.56,57 It has also been suggested thatW161may have
a role in signal transfer following light activation of the
chromophore;60–62 therefore, it is possible that this muta-
tion might affect other cone opsin properties, such as acti-
vation of the phototransduction cascade, as a potential
mechanism affecting cone cell survival. Interestingly,
substitution in rod opsin toW161L orW161F had no effect
on rod opsin folding.60,63 In a mutagenesis study of all the
tryptophan residues in LW opsin, substitution to W177F
and W177Y caused misfolding of the LW opsin protein
and accumulation in the ER, similar to the W177R mutant
described here.64
Mutations in the LW/MW cone opsin array can cause
a wider range of retinal conditions than previously recog-
nized, ranging from the stationary congenital disorders
of cone function, to BCM with progression in later life,
to early-onset retinal degeneration (XLCOD5). There are
now other examples of mutations in genes leading to
both stationary and progressive retinal disorders,
including the genes CNGA3 (MIM 600053), CNGB3 (MIM
605080), and PDE6C (MIM 600827), which are known to
underlie the stationary cone-dysfunction syndrome achro-
matopsia.48 Mutations in these genes have been reported
to also cause progressive COD and CORD.65–67 A new tech-
nique using adaptive optics has been developed to image
the cone photoreceptor mosaic in vivo. Adaptive optics
imaging in dichromatic individuals with a C203R MW
cone opsin mutation has shown that this mutation results
in disruption of the cone photoreceptor mosaic, a reduc-
tion in cone density, and thinning of the outer nuclear
layer.68 The application of this technique to the study of
individuals with cone dysfunction and cone dystrophy,
and correlation of genotypes to cone mosaic and cone
density, is likely to lead to improved understanding of
the functional and visual consequence of cone opsin
mutations.
Successful gene therapy for color vision deﬁciency in
primates has been reported, highlighting the fact that
this approach could be an important treatment strategy
for patients with disorders affecting cone photoreceptors,
such as progressive cone dystrophy resulting from LW/
MWmutations.69 One important consideration for such an
approach will be the evaluation of a potential toxic gain-
of-function or dominant-negative effect of the mutant
protein on the WT opsin introduced to photoreceptors
harboring a preexisting misfolding cone opsin mutation.Supplemental Data
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